Clinical Trial Update: Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE) [NA]

View source ↗

Summary

Clinical trial update for renal denervation using the Vessix system in hypertension (REDUCE HTN:REINFORCE) completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Vessix Renal Denervation System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Hypertension | NA | Status: COMPLETED | Results posted: 2019-10-04